TNKS Protein

TNKS Protein

Introduction

Tnks Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Tankyrase 1 (TNKS) is a 139 kDa poly(ADP-ribose) polymerase encoded by the TNKS gene. As PARP5A, it functions as a key regulator of Wnt signaling, telomere maintenance, mitotic spindle assembly, and protein degradation. Tankyrase 1 is an important therapeutic target in cancer and has emerging roles in neurodegenerative diseases. [@guettler2021]

TNKS Protein

Introduction

Tnks Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Tankyrase 1 (TNKS) is a 139 kDa poly(ADP-ribose) polymerase encoded by the TNKS gene. As PARP5A, it functions as a key regulator of Wnt signaling, telomere maintenance, mitotic spindle assembly, and protein degradation. Tankyrase 1 is an important therapeutic target in cancer and has emerging roles in neurodegenerative diseases. [@guettler2021]

<div class="infobox infobox-protein"> [@sbodio2020]
<table> [@cook2019]
<tr><th colspan="2" style="background:#e8f4ea;">Protein Information</th></tr> [@yang2018]
<tr><td><strong>Protein Name</strong></td><td>Tankyrase 1</td></tr> [@bordin2020]
<tr><td><strong>Gene</strong></td><td>TNKS</td></tr> [@tian2022]
<tr><td><strong>UniProt ID</strong></td><td>Q9Y5X5</td></tr> [@haikarainen2020]
<tr><td><strong>Alternative Names</strong></td><td>PARP5A, TANK1</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~139 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Nucleus, cytoplasm, telomeres</td></tr>
<tr><td><strong>Protein Family</strong></td><td>PARP family (PARP5A)</td></tr>
<tr><td><strong>Length</strong></td><td>1327 amino acids</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">16 edges</a></td>
</tr>
</table>
</div>

Structure

Tankyrase 1 has a complex multidomain architecture:

Ankyrin Repeat Clusters (ANK)

• ANC1 (ankyrins 1-5): N-terminal substrate binding
• ANC2 (ankyrins 6-10): C-terminal substrate binding
• Mediates protein-protein interactions
• Determines substrate specificity

Sterile Alpha Motif (SAM)

• Five SAM domains in the middle region
• Facilitates protein oligomerization
• Required for proper function
• Can mediate homotypic interactions

Catalytic PARP Domain

• C-terminal catalytic domain
• Synthesizes poly(ADP-ribose) chains
• Uses NAD+ as substrate
• Auto-modification capability

REG Domain

• Regulatory domain
• Controls catalytic activity
• Auto-modification site
• Links to ubiquitination

Normal Function

Wnt Signaling Regulation

Tankyrase 1 is a key positive regulator of canonical Wnt/β-catenin signaling:

Telomere Biology

TNKS is essential for telomere maintenance:

• TRF1 interaction: Binds and PARylates TRF1 at telomeres
• Telomere elongation: Promotes telomere lengthening
• Shelterin function: Regulates shelterin complex
• Telomere replication: Aids in telomere DNA replication

Mitotic Spindle

During mitosis, TNKS:

• Localizes to spindle poles
• Regulates microtubule dynamics
• Controls chromosome segregation
• Ensures proper spindle assembly

Protein Quality Control

TNKS links PARylation to degradation:

• Substrate PARylation triggers ubiquitination
• Targets proteins for proteasomal degradation
• Participates in protein quality control pathways

Role in Disease

Cancer

Tankyrase 1 is oncogenic:

• Overexpression: Frequently elevated in many cancers
• Wnt activation: Promotes tumor cell proliferation
• Metastasis: Supports invasion and metastasis
• Therapeutic target: Multiple inhibitors in development

• Colorectal cancer
• Breast cancer
• Lung cancer
• Ovarian cancer
• Gliblastoma

Neurodegeneration

Emerging roles in brain diseases:

• Alzheimer's disease: Wnt signaling dysregulation
• Parkinson's disease: Protein quality control
• Aging: Telomere biology in [neurons](/entities/neurons)

Other Conditions

• Metabolic disorders: Diabetes and obesity links
• Developmental disorders: Embryonic development roles

Therapeutic Targeting

| Strategy | Agent | Stage | Application |
|----------|-------|-------|-------------|
| Small molecule | XAV939 | Preclinical | Dual TNKS1/TNKS2 |
| SAM domain | TEB4 | Research | Blocking interactions |
| Combination | With chemotherapy | Clinical | Resistant tumors |
| PROTACs | Tankyrase degraders | Development | Induced degradation |

Challenges

• Functional redundancy with TNKS2
• Toxicity concerns
• Need for tissue-selective targeting

Biochemical Properties

| Property | Value |
|----------|-------|
| Isoelectric point | 7.2 |
| Oligomeric state | Homooligomer |
| PAR chain length | Up to 25 units |
| Kd for NAD+ | ~40 μM |
| Substrate specificity | Axin, TRF1, 3BP2 |

See Also

• [TNKS Gene](/proteins/tnks-protein)
• [TNKS2 Protein](/proteins/tnks2-protein)
• [Wnt Signaling Pathway](/mechanisms/wnt-signaling)
• [PARP Proteins](/entities/parp-proteins)
• [Telomere Biology](/entities/telomere-biology)
• [Tankyrase Inhibitors](/therapeutics/tankyrase-inhibitors)
• [Colorectal Cancer](/diseases/colorectal-cancer)

External Links

• [UniProt: Q9Y5X5](https://www.uniprot.org/uniprot/Q9Y5X5)
• [NCBI Protein: TNKS](https://www.ncbi.nlm.nih.gov/protein/NP_003977)
• [PDB: TNKS Structure](https://www.rcsb.org/structure/3T0I)
• [PubMed: Tankyrase 1](https://pubmed.ncbi.nlm.nih.gov/?term=tankyrase+1+TNKS)

Background

The study of Tnks Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References